OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PROTAC chemical probes for histone deacetylase enzymes
Urvashi Patel, Joshua P. Smalley, James T. Hodgkinson
RSC Chemical Biology (2023) Vol. 4, Iss. 9, pp. 623-634
Open Access | Times Cited: 9
Urvashi Patel, Joshua P. Smalley, James T. Hodgkinson
RSC Chemical Biology (2023) Vol. 4, Iss. 9, pp. 623-634
Open Access | Times Cited: 9
Showing 9 citing articles:
Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders
Felix Feller, Irina Honin, Martina Miranda, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Felix Feller, Irina Honin, Martina Miranda, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Epigenetic drugs in cancer therapy
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Stimuli-Responsive Prodrugs with Self-Immolative Linker for Improved Cancer Therapy
Xu Wenting, Ang Jia, Zhixian Lei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116928-116928
Closed Access | Times Cited: 2
Xu Wenting, Ang Jia, Zhixian Lei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116928-116928
Closed Access | Times Cited: 2
MDM2 Antagonist Idasanutlin Reduces HDAC1/2 Abundance and Corepressor Partners but Not HDAC3
Joshua P. Smalley, Shaun M. Cowley, James T. Hodgkinson
ACS Medicinal Chemistry Letters (2023) Vol. 15, Iss. 1, pp. 93-98
Open Access | Times Cited: 5
Joshua P. Smalley, Shaun M. Cowley, James T. Hodgkinson
ACS Medicinal Chemistry Letters (2023) Vol. 15, Iss. 1, pp. 93-98
Open Access | Times Cited: 5
Probing Class I Histone Deacetylases (Hdac) with Proteolysis Targeting Chimera (Protac) for the Development of Highly Potent and Selective Degraders
Hany S. Ibrahim, Menglu Guo, Sebastian Hilscher, et al.
(2024)
Closed Access
Hany S. Ibrahim, Menglu Guo, Sebastian Hilscher, et al.
(2024)
Closed Access
Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degraders
Hany S. Ibrahim, Menglu Guo, Sebatian Hilscher, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107887-107887
Open Access
Hany S. Ibrahim, Menglu Guo, Sebatian Hilscher, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107887-107887
Open Access
Cereblon-recruiting proteolysis targeting chimeras (PROTACs) can determine the selective degradation of HDAC1 over HDAC3
Aline Renata Pavan, Joshua P. Smalley, Urvashi Patel, et al.
Chemical Communications (2024)
Open Access
Aline Renata Pavan, Joshua P. Smalley, Urvashi Patel, et al.
Chemical Communications (2024)
Open Access
Correction: Curcio et al. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods. Pharmaceuticals 2024, 17, 620
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1520-1520
Open Access
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1520-1520
Open Access
